Introduction Antibody-mediated rejection (AMR) plays a leading role in transplant immunological injury and, consequently, transplant loss, but presently, we know that not only anti-HLA but also non-HLA antibodies may be significant [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ].
← all excerpts
The Summarized Assessment of Endothelin A Receptor Expression in Renal Transplant Compartments Associated with Antibody-Mediated Rejection.
1
—
—